1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Transforming Cancer Treatment with Immunotherapy (TechVision) 

Transforming Cancer Treatment with Immunotherapy (TechVision) 

  • September 2015
  • -
  • Frost & Sullivan
  • -
  • 51 pages

Transforming cancer treatment with Immunotherapy (TechVision) : Fight cancer with Immunotherapy

Cancer immunotherapy is currently part of a transformative wave that has hit the cancer treatment industry- The progress in this space has been rather substantial on both the technical and commercial front- There have been some high profile FDA approvals for drug candidates, that have shown themselves to be very effective, both as monotherapies and adjunct therapies- Cancer immunotherapy is essentially garnering one’s own immune system and enabling it with the correct tools to attack and destroy the invasive tumors from within- This form of therapy will result in lesser side effects and would be more beneficial than the conventional treatment options that are there- The development of these checkpoint inhibitor treatments, cellular immune therapies, as well as cancer vaccines, is playing a crucial role in the pharmaceutical industry-

Scope

Cancer immunotherapy is currently part of a transformative wave that has hit the cancer treatment industry- The progress in this space has been rather substantial on both the technical and commercial front- There have been some high profile FDA approvals for drug candidates, that have shown themselves to be very effective, both as monotherapies and adjunct therapies- Cancer immunotherapy is essentially garnering one’s own immune system and enabling it with the correct tools to attack and destroy the invasive tumors from within-

This form of therapy will result in lesser side effects and would be more beneficial than the conventional treatment options that are there- The development of these checkpoint inhibitor treatments, cellular immune therapies, as well as cancer vaccines, is playing a crucial role in the pharmaceutical industry-

This research service brings out the emerging trends cancer immunotherapy on a global scale, through a detailed strategic assessment of the industry environment, including:

• Technology overview
• Clinical trial data and technology segmentation, as well ad pertinent drivers and restraints that are impacting the growth of the industry-
• Industrial trends across the entire cancer immunotherapy space and information surrounding venture capital investments
• List of key patents of noteworthy innovations of global participants and a detailed list of key contacts in the field-

Table Of Contents

Transforming Cancer Treatment with Immunotherapy (TechVision) 
1 EXECUTIVE SUMMARY

Executive Summary
1 Scope

2 CANCER IMMUNOTHERAPY SNEAK PEAK

Cancer Immunotherapy Sneak Peak
1 Cancer: A growing global threat
2 Care transformation across cancer
3 Cancer Immunotherapy Segmentation
4 Industry Overview - Main Innovators
5 Technology Roadmap

3 TECHNOLOGY OVERVIEW

Technology Overview
1 Cancer Immunotherapies - Platform Technologies
2 Cancer Immunotherapies - Platform Technologies
3 Types of Cancer Targeted by Immunotherapy
4 Cancer Immunotherapies currently in Phase 3 trials
5 Drivers and Restraints
6 Drivers and Restraints Impact Assessment
7 Drivers Explained
8 Restraints Explained
9 Immune Checkpoint Modulation
10 PD-1 immunotherapies - Innovations
11 Clinical Trial Data - Checkpoint Modulation
12 PD-1 immunotherapies - Treatment Pathway
13 CTLA4 immunotherapies - Innovations
14 Cellular Immune Therapy - Types
15 Clinical Trial Data - Cancer Vaccines
16 Cancer Treatment Vaccines - Types
17 Cancer Vaccines - Innovations
18 Cancer Vaccines- Innovations

4 TRENDS ACROSS CANCER IMMUNOTHERAPY

Trends Across Cancer Immunotherapy
1 Current Industry Trends
2 Venture capital investment
3 Top Venture Capital Investments (2014-2015)
4 Partnerships and Collaborations
5 Partnerships and Collaborations
6 Worldwide Landscape
7 Patent Publishing Trends, Global, 2012?2014
8 Patents per Source Jurisdiction (Top 20 Patent offices), Global, 2012?2014
9 Competitive Benchmarking of Top Patent holders
10 Key Contacts
11 Key Contacts
12 Legal Disclaimer

5 THE FROST and SULLIVAN STORY

The Frost and Sullivan Story
1 The Frost and Sullivan Story
2 Value Proposition: Future of Your Company and Career
3 Global Perspective
4 Industry Convergence
5 360º Research Perspective
6 Implementation Excellence
7 Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Therapy Market in Denmark - Forecast

  • December 2016
    12 pages
  • Therapy  

  • Denmark  

View report >

Related Market Segments :

Therapy
Cancer Immunotherapy

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.